Skip to main content
Log in

Anticoagulation therapy for a LVAD patient with acquired warfarin resistance

  • Case Report
  • Artificial Heart (Clinical)
  • Published:
Journal of Artificial Organs Aims and scope Submit manuscript

Abstract

Anticoagulation therapy with warfarin is essential for postoperative management in patients with left ventricular assist device (LVAD). In this manuscript, we report the case of a patient who developed warfarin resistance after LVAD implantation. Although we administered a novel anticoagulant drug in addition to warfarin and aspirin therapy, the patient developed a major stroke. The patient needed continuous intravenous heparinization until heart transplantation for approximately 2 years. Meticulous management of anticoagulation therapy is essential for a LVAD with warfarin resistance. To our best knowledge, our case is the first case of warfarin resistance in a patient with LVAD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Wever-Pinzon O, Naka Y, Garan AR, Takeda K, Pan S, Takayama H, et al. National trends and outcomes in device-related thromboembolic complications and malfunction among heart transplant candidates supported with continuous-flow left ventricular assist devices in the United States. J Heart Lung Transplant. 2016;35:884–92.

    Article  PubMed  Google Scholar 

  2. Topkara VK, Knotts RJ, Jennings DL, Garan AR, Levin AP, Breskin A, et al. Effect of CYP2C9 and VKORC1 gene variants on warfarin response in patients with continuous-flow left ventricular assist devices. ASAIO J. 2016;62:558–64.

    Article  CAS  PubMed  Google Scholar 

  3. KE OS, Meany B, Hurley JP. Warfarin resistance due to VKORC1 gene mutation in a patient following mechanical aortic valve replacement with an ON-X valve. Int J Cardiol. 2015;188:63–4.

    Article  Google Scholar 

  4. Yasar AS, Balbay Y, Maden O, Sasmaz H. Early mechanical mitral valve thrombosis in a patient with warfarin resistance. J Heart Valve Dis. 2007;16:200–2.

    PubMed  Google Scholar 

  5. Loebstein R, Dvoskin I, Halkin H, Vecsler M, Lubetsky A, Rechavi G, et al. A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistance. Blood. 2007;109:2477–80.

    Article  CAS  PubMed  Google Scholar 

  6. Gellatly RM. Intravenous warfarin as an alternative for anticoagulation. Pharmacotherapy. 2007;27:933–5.

    Article  CAS  PubMed  Google Scholar 

  7. Terrovitis JV, Ntalianis A, Kapelios CJ, Vakrou S, Diakos N, Katsaros L, et al. Dabigatran etexilate as second-line therapy in patients with a left ventricular assist device. Hellenic J Cardiol. 2015;56:20–5.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshiki Sawa.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yoshioka, D., Toda, K., Hidaka, T. et al. Anticoagulation therapy for a LVAD patient with acquired warfarin resistance. J Artif Organs 20, 260–262 (2017). https://doi.org/10.1007/s10047-017-0947-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10047-017-0947-8

Keywords

Navigation